Bipartisan Bill Would Create VA Psychedelics Research Centers for Veterans

Bipartisan support for psychedelic medicine is hitting a new high as Senators Ruben Gallego and David McCormick introduced a bill to establish specialized research hubs within the VA. The Innovative Therapies Centers of Excellence Act proposes $30 million in annual funding to create at least five centers dedicated to studying how substances like psilocybin, MDMA, and ibogaine can treat PTSD and depression in veterans. This Senate move mirrors a House version, signaling a serious, cross-party push to modernize veteran healthcare with "breakthrough" treatments that have already shown massive potential in the private sector.

For the cannabis and plant-medicine community, this is a huge win. It’s not just about the research; it’s about the government finally catching up to the culture by recognizing these substances as legitimate tools for healing rather than just "drugs." As the VA becomes a testing ground for these therapies, it paves the way for broader federal acceptance and improved accessibility for everyone. This shift shows that the "war" on these natural alternatives is finally cooling down in favor of real, life-saving science.